Conversely to SLC38A3, upregulation of SLC38A1, SLC7A6, and SLC1A5 transporters in HCC tumors was associated with decreased overall patient survival, with SLC1A5 being the most significantly associated with tumor aggressiveness. Here, SLC7A6 is linked to hepatocellular carcinoma.